Why I would buy ResMed and these quality blue chips now

I think these blue chips are best buys and worth considering this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Markets do not always move in straight lines.

Even high-quality businesses can see their share prices drift lower during periods of uncertainty. For long-term investors, those moments can create opportunities to accumulate blue chip ASX shares at more attractive levels.

Here are three quality names I would be comfortable buying now.

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.

Image source: Getty Images

ResMed Inc. (ASX: RMD)

The first blue chip ASX share I would consider buying is ResMed.

ResMed is a global leader in sleep disorder treatments. Its devices and cloud-connected software help millions of patients manage conditions such as sleep apnoea and chronic obstructive pulmonary disease.

But the company is still only scratching at the surface of its market opportunity. Management estimates that there are over 1 billion sufferers of sleep apnoea globally. However, the majority of these people don't know they have the condition.

As awareness grows, ResMed stands to benefit greatly as the clear market leader.

In addition, the company has been investing in digital health platforms that link devices to data, improving patient outcomes and strengthening recurring revenue streams. Combined, this blue chip appears well-placed to continue its growth over the next decade and beyond.

Macquarie Group Ltd (ASX: MQG)

Another blue chip ASX share worth a look is Macquarie Group.

Macquarie has built a global reputation in infrastructure, asset management, and specialist financial services. It benefits from exposure to long-term trends such as renewable energy, digital infrastructure, and alternative assets.

Unlike traditional banks, Macquarie's earnings are more diversified across geographies and business lines. This can provide resilience across economic cycles.

With strong capital management and a track record of reinvesting into growth areas, Macquarie remains one of the more dynamic blue-chip names on the ASX.

Wesfarmers Ltd (ASX: WES)

A final blue chip ASX share I would consider this week is Wesfarmers.

It owns businesses such as Bunnings, Kmart, Target, Priceline, Silk Laser, WesCEF, and Officeworks. These are well-known brands with significant scale advantages in their respective markets.

Bunnings in particular has demonstrated pricing power and operational discipline over many years. Meanwhile, Wesfarmers continues to invest in growth areas, including lithium and health, while maintaining a strong balance sheet.

The company's combination of retail leadership, capital allocation discipline, and diversification could make it a reliable long-term holding.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, ResMed, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A woman gives two fist pumps with a big smile as she learns of her windfall, sitting at her desk.
Blue Chip Shares

3 reasons to buy Wesfarmers shares today

The retail conglomerate is a no-brainer buy in my book.

Read more »

ASX shares buy Street signs stating 'Winners' and 'Losers' in front of urban backdrop
Blue Chip Shares

How are these 5 ASX share giants really tracking in 2026?

Some are struggling, while others are thriving, proving that opportunity is never far away.

Read more »

Happy work colleagues give each other a fist pump.
Blue Chip Shares

My best blue-chip ASX 200 buys for April

Looking for quality in uncertain markets? These three ASX 200 shares stand out to me.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »

A happy woman stands outside a building looking at her phone and smiling widely.
Blue Chip Shares

I think smart investors should buy these ASX 200 blue-chip shares with $10,000

Looking for ideas? Here are three ASX 200 blue chips that could help build long-term wealth.

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Blue Chip Shares

Would I buy BHP, CBA, and CSL shares today?

These three ASX 200 leaders have taken different paths lately. Here’s how I’d think about them right now.

Read more »

A man looking at his laptop and thinking.
Blue Chip Shares

3 top blue-chip ASX 200 shares that look dirt cheap right now

A buying opportunity could have opened up for patient investors.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Blue Chip Shares

2 fantastic ASX 200 shares to buy and hold for the next five years

Let's see why these shares could be quality picks for patient investors.

Read more »